Browse studies

Find your next paid study

1 recruiting study matching your filters

A Global, Open-Label, Phase I/II Trial, to Evaluate Safety, Tolerability, Pharmacodynamic and Preliminary Efficacy of JR-446 in Mucopolysaccharidosis Type IIIB (MPS IIIB)

This is a global, open-label, Phase I/II, interventional trial in participants younger than 6 years of age with Mucopolysaccharidosis Type IIIB (MPS IIIB), des…

Mucopolysaccharidosis IIIB

Estimated

~$10 – $8,750

JCR Pharmaceuticals Co., Ltd.NCT07640984